As expected, CD45.1+ cells from prophylactic OM-MOG donor mice showed significantly reduced recruitment to spinal cord meninges compared to CD45.1+ cells from vehicle-treated donor mice (Supplementary Figure 2B). The gene discussed is MOG; the disease is ocular melanoma.